Latest News
Pfizer and AstraZeneca'COVID-19 vaccines found to have strong and similar antibody responses in over 80-year-olds after a first dose
14 April 2021 - The first study in the UK to directly compare immune reactions between Pfizer's and AstraZeneca's COVID-19 vaccines has found strong and broadly similar antibody responses in people aged over 80 after a first dose of either ...
US CDC, FDA Recommend Halt on Use of Johnson and Johnson COVID-19 Vaccine
14 April 2021 - - On April 13 the The United States Centers for Disease Control (CDC) and the US Food and Drug Administration (FDA) issued joint statements regarding the safety of US-based healthcare company Johnson and Johnson's (NYSE: JNJ) (Ja...
US Supermarket Operator Publix Suspends Administration of Johnson and Johnson COVID-19 Vaccine Following Guidance
14 April 2021 - - US-based supermarket chain Publix is suspending the administration of the Johnson and Johnson (NYSE: JNJ) COVID-19 vaccine at all of its pharmacy locations following guidance from the US Centers for Disease Control and Prevention an...
Infinity BiologiX Awarded CDC Contract to Sequence Variants of COVID-19 Virus and Assist in Global Public Health Response
14 April 2021 - - US-based central laboratory Infinity BiologiX has been awarded a contract from the Centers for Disease Control and Prevention "Genomic Surveillance for SARS-CoV-2 Variants," to provide genomic sequencing and new variant id...
Endourage Begins Human Clinical Trial to Test If Proprietary Hemp-Flower Formulation Eases Symptoms of Post-Acute COVID-19 Syndrome
14 April 2021 - - Denver, US-based CBD company Endourage has received authorization from an Institutional Review Board for its Phase IV clinical trial to evaluate the efficacy of its proprietary hemp flower CBD formulation, Targeted Wellness Formula ...